Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Development of Western Medicine and Marketing Department	788.71M	784.93M	721.91M	726.66M	709.95M
Development of Western Medicine and Marketing Department Growth	0.48%	8.73%	-0.65%	2.35%	-8.84%
Western Medicine Manufacturing Department	485.87M	533.31M	491.47M	426.28M	492.54M
Western Medicine Manufacturing Department Growth	-8.90%	8.51%	15.29%	-13.45%	18.54%
Adjustment and Write-Off	-379.27M	-378.30M	-347.11M	-328.83M	-336.38M
Total	895.32M	939.94M	866.27M	824.10M	866.11M
Total Growth	-4.75%	8.50%	5.12%	-4.85%	-1.35%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Singapore	91.03M	139.17M	138.71M	24.37M	-
Singapore Growth	-34.59%	0.33%	469.25%	-	-
Japan	483.00K	510.00K	574.00K	19.35M	153.04M
Japan Growth	-5.29%	-11.15%	-97.03%	-87.36%	25.58%
Taiwan	621.94M	632.19M	561.86M	579.90M	621.70M
Taiwan Growth	-1.62%	12.52%	-3.11%	-6.72%	-0.82%
China	51.94M	19.27M	27.23M	32.52M	27.53M
China Growth	169.53%	-29.23%	-16.26%	18.14%	-60.32%
Others	967.00K	1.29M	911.00K	487.00K	264.00K
Others Growth	-24.75%	41.05%	87.06%	84.47%	-96.30%
Europe	128.96M	147.51M	136.99M	167.48M	63.59M
Europe Growth	-12.58%	7.68%	-18.21%	163.38%	20.59%
Total	895.32M	939.94M	866.27M	824.10M	866.11M
Total Growth	-4.75%	8.50%	5.12%	-4.85%	-1.35%

Source: S&P Global Market Intelligence.